AMPLIPHI BIOSCIENCES CORPORATION FIRST AMENDMENT TO COMMON STOCK ISSUANCE AGREEMENTCommon Stock Issuance Agreement • June 30th, 2017 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 30th, 2017 Company Industry JurisdictionThis First Amendment to Common Stock Issuance Agreement (this “Amendment”) is made as of June 27, 2017, by and among AmpliPhi Biosciences Corporation, a Washington corporation (the “Company”), and the persons and entities listed on Exhibit A hereto (each, a “Holder” and collectively, the “Holders”). All capitalized terms used in this Amendment but not defined herein shall have their respective meanings as set forth in the Agreement.